Recruiting
Phase 2

Daridorexant

Sponsor:

Douglas Mental Health University Institute

Code:

NCT07213349

Conditions

Alzheimer Disease (AD)

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Accepted

Interventions

Daridorexant 50 mg

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-24. This information was provided to ClinicalTrials.gov by Douglas Mental Health University Institute on 2025-12-19.